Table 2. Demographic & clinical characteristics of 127 patients for MVI task.
| Demographic and clinical characteristics | Total | MVI present/MVI absent | P value |
|---|---|---|---|
| Number of patients | 127 | 77/50 | – |
| Age (years), median (range) | 55±28 | 55±28/56±27 | 0.486 |
| Gender | 0.347 | ||
| Male | 79 | 48/31 | |
| Female | 33 | 16/17 | |
| AFP (ng/mL) | 0.1 | ||
| ≥20 | 39 | 21/18 | |
| <20 | 73 | 43/30 | |
| CA19-9 (U/mL) | 0.399 | ||
| ≤37 | 74 | 43/31 | |
| >37 | 38 | 21/17 | |
| Tumor size (mm) | 0.0009 | ||
| 3 | 21 | 9/12 | |
| 5 | 34 | 16/18 | |
| 10 | 38 | 25/13 | |
| >10 | 21 | 14/7 | |
| Tumor stage | 0.090 | ||
| A | 33 | 11/22 | |
| B | 46 | 30/16 | |
| C | 33 | 23/10 | |
| Tumor amount | 0.031 | ||
| Multiple | 12 | 10/2 | |
| Single | 100 | 54/46 | |
| Satellite node | 0.359 | ||
| None | 81 | 32/49 | |
| 1–3 | 41 | 32/9 |
AFP, alpha-fetoprotein; CA19-9, carbohydrate antigen 19-9; MVI, microvascular invasion.